Robert Peter Pauly

Robert Peter Pauly

Auto-generated profile, based on publicly available information

Robert Peter Pauly

Division of Nephrology, University of Alberta, Edmonton, Canada

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2009 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
RPRobert P. Pauly
Robert P. Pauly
JGJohn S. Gill
John S. Gill
CRCaren L. Rose
Caren L. Rose
RAReem A. Asad
Reem A. Asad
ACAnne Chery
Anne Chery
CCChristopher T. Chan
Christopher T. Chan
Background. Kidney transplantation is the gold standard renal replacement therapy. Nocturnal haemodialysis (NHD) is an intensive dialysis modality (6–8 h/session, 3–7 sessions/week) associated with a significant improvement of clinical and biochemical parameters compared to conventional dialysis. To date, no studies have compared survival in patients treated with NHD and kidney transplantation. Methods. Using data from two regional NHD programmes and the USRDS from 1994 to 2006, we performed a matched cohort study comparing survival between NHD and deceased and living donor kidney transplantation (DTX and LTX) by randomly matching NHD patients to transplant recipients in a 1:3:3 ratio. The independent association of treatment modality with survival was determined using Cox multivariate regression. Results. The total study population consisted of 177 NHD patients matched to 1062 DTX and LTX recipients (total 1239 patients) followed for a maximum of 12.4 years. During the follow-up period, the proportion of deaths among NHD, DTX and LTX patients was 14.7%, 14.3% and 8.5%, respectively ( P = 0.006). We found no difference in the adjusted survival between NHD and DTX (HR 0.87, 95% CI 0.50–1.51; NHD reference group), while LTX survival was better (HR 0.51, 95% CI 0.28–0.91). Conclusions. These results indicate that NHD and DTX survival is comparable, and suggest that this intensive dialysis modality may be a bridge to transplantation or even a suitable alternative in the absence of LTX in the current era of growing transplant waiting lists and organ shortage.

1 October 2010 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
RPRobert P. Pauly
Robert P. Pauly
KMKaterina Maximova
Katerina Maximova
JCJennifer Coppens
Jennifer Coppens
RAReem A. Asad
Reem A. Asad
APAndreas Pierratos
Andreas Pierratos
OGon behalf of the CAN-SLEEP Collaborative Group
on behalf of the CAN-SLEEP Collaborative Group
Background and objectives: As a result of improved clinical and quality-of-life outcomes compared with conventional hemodialysis, interest in nocturnal home hemodialysis (NHD) has steadily increased in the past decade; however, little is known about the flow of patients through NHD programs or about patient-specific predictors of mortality or technique failure associated with this modality. This study addressed this gap in knowledge. Design, setting, participants, & measurements: This study included 247 NHD patients of the Canadian Slow Long nightly ExtEnded dialysis Programs (CAN-SLEEP) cohort from 1994 through 2006 inclusive. The association between program- and patient-specific variables and risk for adverse outcomes was determined using uni- and multivariable Cox regression. Results: A total of 14.6% of the cohort experienced death or technique failure. Unadjusted 1- and 5-year adverse event-free survival was 95.2 and 80.1%, respectively. Significant predictors of a composite of mortality and technique failure included advanced age (P < 0.001), diabetes (P < 0.001), central venous catheter use (P = 0.01), and inability to perform NHD independently (P = 0.009) and were adjusted for center effect. Weekly frequency of NHD was not predictive. Age and diabetes remained significant with multivariable analysis (hazard ratio 1.07 and 2.64, respectively). Unadjusted 1- and 5-year technique survival was 97.9 and 95.2%, respectively. Only age was a significant predictor of technique failure. Conclusions: NHD is associated with excellent adverse event-free survival. This study underscores the importance of modality-specific predictors in the success of home hemodialysis, as well as favorable baseline characteristics such as younger age and the absence of diabetes.

1 February 2014 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
BWBen Wong
Ben Wong
DZDeborah Zimmerman
Deborah Zimmerman
FRFrances Reintjes
Frances Reintjes
MCMark Courtney
Mark Courtney
SKScott Klarenbach
Scott Klarenbach
RPRobert P. Pauly
Robert P. Pauly

24 July 2017 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
NSNikhil Shah
Nikhil Shah
FRFrances Reintjes
Frances Reintjes
MCMark Courtney
Mark Courtney
SKScott W. Klarenbach
Scott W. Klarenbach
FYFeng Ye
Feng Ye
RPRobert P. Pauly
Robert P. Pauly
Background and objectives: Little is known about patients exiting home hemodialysis. We sought to characterize the reasons, clinical characteristics, and pre-exit health care team interactions of patients on home hemodialysis who died or underwent modality conversion (negative disposition) compared with prevalent patients and those who were transplanted (positive disposition). Design, setting, participants, & measurements: We conducted an audit of all consecutive patients incident to home hemodialysis from January of 2010 to December of 2014 as part of ongoing quality assurance. Records were reviewed for the 6 months before exit, and vital statistics were assessed up to 90 days postexit. Results: Ninety-four patients completed training; 25 (27%) received a transplant, 11 (12%) died, and 23 (25%) were transferred to in-center hemodialysis. Compared with the positive disposition group, patients in the negative disposition group had a longer mean dialysis vintage (3.15 [SD=4.98] versus 1.06 [SD=1.16] years; P=0.003) and were performing conventional versus a more intensive hemodialysis prescription (23 of 34 versus 23 of 60; P<0.01). In the 6 months before exit, the negative disposition group had significantly more in-center respite dialysis sessions, had more and longer hospitalizations, and required more on-call care team support in terms of phone calls and drop-in visits (each P<0.05). The most common reason for modality conversion was medical instability in 15 of 23 (65%) followed by caregiver or care partner burnout in three of 23 (13%) each. The 90-day mortality among patients undergoing modality conversion was 26%. Conclusions: Over a 6-year period, approximately one third of patients exited the program due to death or modality conversion. Patients who die or transfer to another modality have significantly higher health care resource utilization (e.g., hospitalization, respite treatments, nursing time, etc.).

29 April 2015 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
RPRobert P. Pauly
Robert P. Pauly
DEDeborah O. Eastwood
Deborah O. Eastwood
MMMark R. Marshall
Mark R. Marshall

1 January 2013 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PDF file
RPRobert P. Pauly
Robert P. Pauly
Our contemporary paradigms of nocturnal and short-daily hemodialysis (NHD and SDHD) have their origins in the earliest era of dialysis care for end-stage renal disease. However, these therapies have received considerably more attention in recent years owing to an increasing body of literature, suggesting a myriad of benefits attributable to these intensive dialysis regimens compared with conventional thrice-weekly hemodialysis. Analyses suggest a survival benefit for NHD and SDHD versus traditional hemodialysis prescriptions, and it is in this context that survival comparisons between intensive dialysis and transplantation must be considered. This literature and its limitations are reviewed here.